Aneel A. Ashrani - Concepedia

Author

Aneel A. Ashrani

Also Known As

A A Ashrani, A Ashrani, A. A. ASHRANI, A. A. Ashrani, A. Ashrani, A.A. Ashrani, Addison, Clifton, Alan S Go, Allison Ashley-Koch, Aneel A Ashrani

196

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Arizona Mayo Clinic in Florida WinnMed University of Colorado Denver

About

Aneel A. Ashrani is an author at Mayo Clinic specializing in medicine, thrombosis, and pulmonary embolism.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	37	2.8K
2	Public Health	16	18	1.1K
3	Health Sciences	5	5	371
4	Nursing	2	2	20
5	Allergy	1	1	22

Aneel A. Ashrani

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial Robert D. McBane, Waldemar E. Wysokiński, Jennifer Le‐Rademacher, Journal of Thrombosis and Haemostasis ThrombosisVenous ThrombosisAdam Vte TrialHematologyPharmacology	2019	554
Genetic diversity fuels gene discovery for tobacco and alcohol use Gretchen Saunders, Xingyan Wang, Fang Chen, Nature	2022	470
NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018 Michael B. Streiff, Bjorn Holmstrom, Dana E. Angelini, Journal of the National Comprehensive Cancer Network Cancer ManagementNccn Guidelines InsightsPathologyPharmacotherapyCancer-associated Vte	2018	241
Cancer-Associated Venous Thromboembolic Disease, Version 1.2015 Michael B. Streiff, Bjorn Holmstrom, Aneel A. Ashrani, Journal of the National Comprehensive Cancer Network Version 1.2015PathologyEffective ProphylaxisPharmacotherapyThrombosis	2015	216
Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study Cheng E. Chee, Aneel A. Ashrani, Randolph S. Marks, Blood	2014	207
Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Michael B. Streiff, Bjorn Holmstrom, Dana E. Angelini, PubMed Surgical OncologyCancer ManagementPharmacotherapyThrombosisVenous Thrombosis	2021	152
Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology Michael B. Streiff, Bjorn Holmstrom, Dana E. Angelini, Journal of the National Comprehensive Cancer Network Cancer ManagementPharmacotherapyCancer-associated VteVersion 2.2024Thrombosis	2024	143
Reasons for the persistent incidence of venous thromboembolism John A. Heit, Aneel A. Ashrani, Daniel J. Crusan, Thrombosis and Haemostasis	2016	117
Is Diabetes Mellitus an Independent Risk Factor for Venous Thromboembolism? John A. Heit, Cynthia L. Leibson, Aneel A. Ashrani, Arteriosclerosis Thrombosis and Vascular Biology	2009	115
Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US John A. Heit, Daniel J. Crusan, Aneel A. Ashrani, Blood	2017	109

Page 1